MedTrace Logo

Bright Light Therapy as Possible Treatment Option for MS-Fatigue

NCT04681586 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2020-12-23

No results posted yet for this study

Summary

This study aims to investigate the effect of a 2-week trial of bright light therapy (BLT, 10.000 lx) on fatigue in multiple sclerosis (MS) patients. In this randomised placebo-controlled trial, the effect of bright light therapy will be compared to dim red light. MS-fatigue is quantified by patients using a visual analogue scale (VAS) and activity levels, subjective and objective sleep parameters and daytime sleepiness are measured.

Conditions

Interventions

DEVICE

bright light therapy

using a bright light therapy device (10.000 lux) for 30min every morning for two weeks

DEVICE

dim red light

using the same device as the active group, but with an installed filter that dims light to \<300 lux for 30min every morning for two weeks

Sponsors & Collaborators

  • National Bank of Austria

    collaborator OTHER_GOV

  • Medical University of Vienna

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2021-09-30
Completion
2022-01-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04681586 on ClinicalTrials.gov